title: Proposal for the classification of relapsed and refractory acute myeloid leukemias as the basis for an age-adjusted randomized comparison of sequentially applied high-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone (S-HAM).
authors.affiliation: Department of Internal Medicine, University of Münster.
authors.forename: W
authors.initials: W
authors.lastname: Hiddemann
authors.forename: H C
authors.initials: HC
authors.lastname: Aul
authors.forename: G
authors.initials: G
authors.lastname: Maschmeyer
authors.forename: D
authors.initials: D
authors.lastname: Urbanitz
authors.forename: B
authors.initials: B
authors.lastname: Lathan
authors.forename: A
authors.initials: A
authors.lastname: Reichle
authors.forename: H
authors.initials: H
authors.lastname: Köppler
authors.forename: R
authors.initials: R
authors.lastname: Donhuijsen-Ant
authors.forename: W D
authors.initials: WD
authors.lastname: Ludwig
authors.forename: T
authors.initials: T
authors.lastname: Grüneisen
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001317:Austria / Q000453:epidemiology; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage / Q000493:pharmacokinetics; D003630:Daunorubicin / Q000008:administration & dosage; D004351:Drug Resistance; D005860:Germany, West; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy* / Q000401:mortality; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D015337:Multicenter Studies as Topic; D009364:Neoplasm Recurrence, Local / Q000145:classification / Q000188:drug therapy*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D013866:Thioguanine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D008942:Mitoxantrone; D013866:Thioguanine; D003630:Daunorubicin